| Eculizumab treatment in patients with COVID-19: preliminary results from real life ASL Napoli 2 Nord experience. F Diurno, FG Numis, G Porta, F Cirillo, S Maddaluno, A Ragozzino, ... European Review for Medical & Pharmacological Sciences 24 (7), 2020 | 387 | 2020 |
| Serum markers of hepatocellular carcinoma G Malaguarnera, M Giordano, I Paladina, M Berretta, A Cappellani, ... Digestive diseases and sciences 55, 2744-2755, 2010 | 308 | 2010 |
| Rituximab plus infusional cyclophosphamide, doxorubicin, and etoposide in HIV-associated non-Hodgkin lymphoma: pooled results from 3 phase 2 trials M Spina, U Jaeger, JA Sparano, R Talamini, C Simonelli, M Michieli, ... Blood 105 (5), 1891-1897, 2005 | 231 | 2005 |
| Ifosfamide in the adjuvant therapy of soft tissue sarcomas S Frustaci, A De Paoli, E Bidoli, N La Mura, M Berretta, A Buonadonna, ... Oncology 65 (Suppl. 2), 80-84, 2003 | 200 | 2003 |
| Editorial–Differences and similarities between Severe Acute Respiratory Syndrome (SARS)-CoronaVirus (CoV) and SARS-CoV-2. Would a rose by another name smell as sweet M Ceccarelli, M Berretta, EV Rullo, G Nunnari, B Cacopardo European review for medical and pharmacological sciences 24 (5), 2781-2783, 2020 | 198 | 2020 |
| Epithelial-mesenchymal transition in prostate cancer: an overview M Montanari, S Rossetti, C Cavaliere, C D'Aniello, MG Malzone, ... Oncotarget 8 (21), 35376, 2017 | 188 | 2017 |
| Microbiota effects on cancer: from risks to therapies D Rea, G Coppola, G Palma, A Barbieri, A Luciano, P Del Prete, ... Oncotarget 9 (25), 17915, 2018 | 182 | 2018 |
| A 12-gene pharmacogenetic panel to prevent adverse drug reactions: an open-label, multicentre, controlled, cluster-randomised crossover implementation study JJ Swen, CH van der Wouden, LEN Manson, H Abdullah-Koolmees, ... The Lancet 401 (10374), 347-356, 2023 | 172 | 2023 |
| Use of Complementary and Alternative Medicine (CAM) in cancer patients: An Italian multicenter survey M Berretta, C Della Pepa, P Tralongo, A Fulvi, F Martellotta, A Lleshi, ... Oncotarget 8 (15), 24401, 2017 | 171 | 2017 |
| Hepatocellular carcinoma in HIV‐infected patients: Check early, treat hard M Berretta, E Garlassi, B Cacopardo, A Cappellani, G Guaraldi, S Cocchi, ... The oncologist 16 (9), 1258-1269, 2011 | 153 | 2011 |
| Kaposi’s sarcoma in HIV-positive patients: the state of art in the HAART-era L La Ferla, MR Pinzone, G Nunnari, F Martellotta, A Lleshi, U Tirelli, ... Eur Rev Med Pharmacol Sci 17 (17), 2354-2365, 2013 | 147 | 2013 |
| Radical radiation therapy for oligometastatic breast cancer: results of a prospective phase II trial M Trovo, C Furlan, J Polesel, F Fiorica, S Arcangeli, N Giaj-Levra, ... Radiotherapy and Oncology 126 (1), 177-180, 2018 | 146 | 2018 |
| Activity of pemetrexed on brain metastases from non-small cell lung cancer A Bearz, I Garassino, M Tiseo, O Caffo, H Soto-Parra, M Boccalon, ... Lung Cancer 68 (2), 264-268, 2010 | 145 | 2010 |
| Modulated chemotherapy according to modified comprehensive geriatric assessment in 100 consecutive elderly patients with diffuse large B-cell lymphoma M Spina, M Balzarotti, L Uziel, AJM Ferreri, L Fratino, M Magagnoli, ... The oncologist 17 (6), 838-846, 2012 | 142 | 2012 |
| Anticancer and Anti-Inflammatory Properties of Ganoderma lucidum Extract Effects on Melanoma and Triple-Negative Breast Cancer Treatment A Barbieri, V Quagliariello, V Del Vecchio, M Falco, A Luciano, ... Nutrients 9 (3), 210, 2017 | 131 | 2017 |
| AIDS-related Kaposi's sarcoma: state of the art and therapeutic strategies F Martellotta, M Berretta, E Vaccher, O Schioppa, E Zanet, U Tirelli Current HIV research 7 (6), 634-638, 2009 | 130 | 2009 |
| Prognostic and predictive response factors in colorectal cancer patients: between hope and reality C De Divitiis, G Nasti, M Montano, R Fisichella, RV Iaffaioli, M Berretta World Journal of Gastroenterology: WJG 20 (41), 15049, 2014 | 126 | 2014 |
| Impact of highly active antiretroviral therapy on the presenting features and outcome of patients with Acquired Immunodeficiency Syndrome–Related Kaposi sarcoma G Nasti, F Martellotta, M Berretta, M Mena, M Fasan, G Di Perri, ... Cancer 98 (11), 2440-2446, 2003 | 122 | 2003 |
| Serum markers of intrahepatic cholangiocarcinoma G Malaguarnera, I Paladina, M Giordano, M Malaguarnera, G Bertino, ... Disease markers 34 (4), 219-228, 2013 | 119 | 2013 |
| Solid pseudopapillary tumour of the pancreas V Canzonieri, M Berretta, A Buonadonna, E Vasquez, E Barbagallo, ... The lancet oncology 4 (4), 255-256, 2003 | 103 | 2003 |
GAETANO FACCHINIDirector of Medical Oncology Unit - ASL Napoli 2 Nord - Pozzuoli-IschiaEmail verificata su aslnapoli2nord.it
